Rennova Health Stock Forecast, Price & News

0.00 (0.00 %)
(As of 07/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume616,881 shs
Average Volume282.44 million shs
Market Capitalization$530 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive RNVA News and Ratings via Email

Sign-up to receive the latest news and ratings for Rennova Health and its competitors with MarketBeat's FREE daily newsletter.

Rennova Health logo

About Rennova Health

Rennova Health, Inc., together with its subsidiaries, engages in the hospital operations in the United States. As of March 31, 2021, it owns one operating hospital in Oneida, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company was founded in 2005 and is based in West Palm Beach, Florida.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.99 out of 5 stars

Medical Sector

1403rd out of 2,218 stocks

General Medical & Surgical Hospitals Industry

8th out of 13 stocks

Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Rennova Health (OTCMKTS:RNVA) Frequently Asked Questions

What stocks does MarketBeat like better than Rennova Health?

Wall Street analysts have given Rennova Health a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Rennova Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Rennova Health?

Rennova Health saw a increase in short interest in July. As of July 15th, there was short interest totaling 289,100 shares, an increase of 83.1% from the June 30th total of 157,900 shares. Based on an average daily trading volume, of 665,145,400 shares, the days-to-cover ratio is currently 0.0 days.
View Rennova Health's Short Interest

When is Rennova Health's next earnings date?

Rennova Health is scheduled to release its next quarterly earnings announcement on Thursday, August 12th 2021.
View our earnings forecast for Rennova Health

How were Rennova Health's earnings last quarter?

Rennova Health, Inc. (OTCMKTS:RNVA) released its quarterly earnings data on Tuesday, August, 14th. The company reported $250,000.00 earnings per share (EPS) for the quarter. The business earned $3.29 million during the quarter.
View Rennova Health's earnings history

How has Rennova Health's stock been impacted by Coronavirus (COVID-19)?

Rennova Health's stock was trading at $0.10 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, RNVA stock has decreased by 47.0% and is now trading at $0.0530.
View which stocks have been most impacted by COVID-19

When did Rennova Health's stock split? How did Rennova Health's stock split work?

Shares of Rennova Health reverse split on the morning of Monday, July 19th 2021. The 1-1000 reverse split was announced on Monday, July 19th 2021. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 19th 2021. An investor that had 100 shares of Rennova Health stock prior to the reverse split would have 0 shares after the split.

Who are Rennova Health's key executives?

Rennova Health's management team includes the following people:
  • Mr. Seamus Lagan, Pres, CEO, Interim CFO & Director (Age 52, Pay $487k)
  • Ms. Karen Taylor, Director of HR
  • Mr. Albert F. Lechner, Exec. VP of Sales - Rennova Health Technology Solutions
  • Mr. Michael Alexander, CEO of Jamestown Medical Center, Inc.
  • Mr. Sebastien Sainsbury, Company Sec. & PR
  • Ms. Kristi Dymond, Treasurer

Who are some of Rennova Health's key competitors?

What other stocks do shareholders of Rennova Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rennova Health investors own include Neovasc (NVCN), Himax Technologies (HIMX), Precipio (PRPO), CytRx (CYTR), Heat Biologics (HTBX), Biopharmx (BPMX), Delcath Systems (DCTHD), Immune Pharmaceuticals (IMNP), Protalix BioTherapeutics (PLX) and 22nd Century Group (XXII).

What is Rennova Health's stock symbol?

Rennova Health trades on the OTCMKTS under the ticker symbol "RNVA."

How do I buy shares of Rennova Health?

Shares of RNVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Rennova Health's stock price today?

One share of RNVA stock can currently be purchased for approximately $0.05.

How much money does Rennova Health make?

Rennova Health has a market capitalization of $530 million and generates $7.20 million in revenue each year.

How many employees does Rennova Health have?

Rennova Health employs 63 workers across the globe.

What is Rennova Health's official website?

The official website for Rennova Health is www.rennovahealth.com.

Where are Rennova Health's headquarters?

Rennova Health is headquartered at 931 Village Boulevard Suite 905, West Palm Beach FL, 33409.

How can I contact Rennova Health?

Rennova Health's mailing address is 931 Village Boulevard Suite 905, West Palm Beach FL, 33409. The company can be reached via phone at 561-855-1626 or via email at [email protected]

This page was last updated on 7/28/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.